window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

Clinical Data

  • Artificial Intelligence,Clinical Trials,Data Management,Drug Development,Technology and platforms

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    October 12, 2025
  • Events and Conferences,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    September 22, 2025
  • Clinical Development,Clinical Trials,Technology and platforms

    PHARMASEAL and Viedoc integrate platforms to streamline clinical trial oversight

    Partnership combines PHARMASEAL’s trial management technology with Viedoc’s electronic data [...]

    July 9, 2025
  • Clinical Development,Drug Development,Regulatory Affairs,Technology and platforms

    Certara expands clinical data collaboration with Merck to enhance digital trial efficiency

    Merck to broaden use of Certara’s Pinnacle 21 platform, adding [...]

    July 9, 2025
  • Artificial Intelligence,Clinical Trials,Regulatory Affairs

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 27, 2025
  • Artificial Intelligence,Clinical Trials

    Lokavant launches AI-powered forecasting tool to cut clinical trial planning time from weeks to minutes

    April 25, 2025
  • Clinical Trials

    Shilpa Medicare’s Nor-UDCA tablets advance in India: SEC recommends marketing authorization following positive phase 3 results

    April 22, 2025
  • Clinical Trials

    AI appetite slows as clinical trial leaders refocus on risk-based strategies

    April 22, 2025
  • Artificial Intelligence

    New research from eClinical Solutions highlights AI adoption and focus on risk-based strategies in 2025

    June 5, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top